Biophysical Determinants for the Viscosity of Concentrated Monoclonal Antibody Solutions.

MD simulations monoclonal antibodies quasi-elastic neutron scattering self-association self-diffusion small-angle neutron scattering

Journal

Molecular pharmaceutics
ISSN: 1543-8392
Titre abrégé: Mol Pharm
Pays: United States
ID NLM: 101197791

Informations de publication

Date de publication:
04 09 2023
Historique:
medline: 5 9 2023
pubmed: 7 8 2023
entrez: 7 8 2023
Statut: ppublish

Résumé

Monoclonal antibodies (mAbs) are particularly relevant for therapeutics due to their high specificity and versatility, and mAb-based drugs are hence used to treat numerous diseases. The increased patient compliance of self-administration motivates the formulation of products for subcutaneous (SC) administration. The associated challenge is to formulate highly concentrated antibody solutions to achieve a significant therapeutic effect, while limiting their viscosity and preserving their physicochemical stability. Protein-protein interactions (PPIs) are in fact the root cause of several potential problems concerning the stability, manufacturability, and delivery of a drug product. The understanding of macroscopic viscosity requires an in-depth knowledge on protein diffusion, PPIs, and self-association/aggregation. Here, we study the self-diffusion of different mAbs of the IgG1 subtype in aqueous solution as a function of the concentration and temperature by quasi-elastic neutron scattering (QENS). QENS allows us to probe the short-time self-diffusion of the molecules and therefore to determine the hydrodynamic mAb cluster size and to gain information on the internal mAb dynamics. Small-angle neutron scattering (SANS) is jointly employed to probe structural details and to understand the nature and intensity of PPIs. Complementary information is provided by molecular dynamics (MD) simulations and viscometry, thus obtaining a comprehensive picture of mAb diffusion.

Identifiants

pubmed: 37549226
doi: 10.1021/acs.molpharmaceut.3c00440
doi:

Substances chimiques

Antibodies, Monoclonal 0
Immunoglobulin G 0
Solutions 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

4698-4713

Auteurs

Ilaria Mosca (I)

Institut für Angewandte Physik, Universität Tübingen, Auf der Morgenstelle 10, Tübingen 72076, Germany.
Institut Max von Laue - Paul Langevin, 71 Av. des Martyrs, Grenoble 38042, France.

Kévin Pounot (K)

Institut für Angewandte Physik, Universität Tübingen, Auf der Morgenstelle 10, Tübingen 72076, Germany.
Institut Max von Laue - Paul Langevin, 71 Av. des Martyrs, Grenoble 38042, France.

Christian Beck (C)

Institut für Angewandte Physik, Universität Tübingen, Auf der Morgenstelle 10, Tübingen 72076, Germany.
Institut Max von Laue - Paul Langevin, 71 Av. des Martyrs, Grenoble 38042, France.

Louise Colin (L)

Institut für Angewandte Physik, Universität Tübingen, Auf der Morgenstelle 10, Tübingen 72076, Germany.
Institut Max von Laue - Paul Langevin, 71 Av. des Martyrs, Grenoble 38042, France.

Olga Matsarskaia (O)

Institut Max von Laue - Paul Langevin, 71 Av. des Martyrs, Grenoble 38042, France.

Christoph Grapentin (C)

Lonza AG/Ltd., Hochbergerstrasse 60G, Basel 4057, Switzerland.

Tilo Seydel (T)

Institut Max von Laue - Paul Langevin, 71 Av. des Martyrs, Grenoble 38042, France.

Frank Schreiber (F)

Institut für Angewandte Physik, Universität Tübingen, Auf der Morgenstelle 10, Tübingen 72076, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH